Reference health

36‐month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease

https://doi.org/10.1002/alz.12172
CiteStamped reference-health badge
33/33 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 33 checked references that resolve
resolves10.1016/S0140-6736(17)31363-6
Dementia prevention, intervention, and care
resolves10.3390/nu10101557
Mediterranean Lifestyle in Relation to Cognitive Health: Results from the HELIAD Study
resolves10.1017/S0007114517001982
Nutrient intake and dietary changes during a 2-year multi-domain lifestyle intervention among older adults: secondary analysis of the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) randomised controlled trial
resolves10.3233/JAD-130998
Targeting Synaptic Dysfunction in Alzheimer's Disease by Administering a Specific Nutrient Combination
resolves10.1016/S0006-8993(03)03320-1
Dietary fatty acids alter blood pressure, behavior and brain membrane composition of hypertensive rats
resolves10.1016/S1074-7427(03)00024-8
Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats
resolves10.3233/JAD-2011-110635
Neuroprotective Effects of a Specific Multi-Nutrient Intervention Against Aβ42-Induced Toxicity in Rats
resolves10.3233/JAD-2012-112039
A Specific Multi-Nutrient Diet Reduces Alzheimer-Like Pathology in Young Adult AβPPswe/PS1dE9 Mice
resolves10.1371/journal.pone.0075393
Effects of Specific Multi-Nutrient Enriched Diets on Cerebral Metabolism, Cognition and Neuropathology in AβPPswe-PS1dE9 Mice
resolves10.1016/j.neurobiolaging.2013.09.038
Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease
resolves10.1016/j.jnutbio.2013.09.015
Special lipid-based diets alleviate cognitive deficits in the APPswe/PS1dE9 transgenic mouse model of Alzheimer's disease independent of brain amyloid deposition
resolves10.1194/jlr.R076331
Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention
resolves10.1016/j.jalz.2009.10.003
Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial
resolves10.3233/JAD-2012-121189
Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial
resolves10.1186/alzrt224
The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease
resolves10.1186/s13195-019-0528-6
Souvenaid in the management of mild cognitive impairment: an expert consensus opinion
resolves10.1016/S1474-4422(07)70178-3
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
resolves10.1016/S1474-4422(17)30332-0
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial
resolves10.14283/jpad.2019.33
Alzheimer's Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer's Disease
resolves10.1186/s13195-015-0134-1
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease
resolves10.1186/s12874-019-0791-z
Using joint models to disentangle intervention effect types and baseline confounding: an application within an intervention study in prodromal Alzheimer’s disease with Fortasyn Connect
resolves10.18637/jss.v035.i09
<b>JM</b>: An<i>R</i>Package for the Joint Modelling of Longitudinal and Time-to-Event Data
resolves10.1016/S0140-6736(16)30950-3
Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial
resolves10.1002/sim.2249
Shared parameter models for the joint analysis of longitudinal data and event times
resolves10.1201/b12208
Joint Models for Longitudinal and Time-to-Event Data
resolves10.1038/psp.2013.54
Modeling Alzheimer's Disease Progression Using Disease Onset Time and Disease Trajectory Concepts Applied to CDR‐SOB Scores From ADNI
resolves10.3233/JAD-132090
Predicting the Time to Clinically Worsening in Mild Cognitive Impairment Patients and its Utility in Clinical Trial Design by Modeling a Longitudinal Clinical Dementia Rating Sum of Boxes from the ADNI Database
resolves10.2147/NDT.S62323
Disease progression model for Clinical Dementia Rating&amp;ndash;Sum of Boxes in mild cognitive impairment and Alzheimer&amp;rsquo;s subjects from the Alzheimer&amp;rsquo;s Disease Neuroimaging Initiative
resolves10.1212/WNL.0b013e318207b1b9
Report of the task force on designing clinical trials in early (predementia) AD
resolves10.1016/j.neuroimage.2015.10.065
Integrating longitudinal information in hippocampal volume measurements for the early detection of Alzheimer's disease
resolves10.1212/WNL.55.4.484
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
resolves10.1136/jnnp.2003.029074
Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease
resolves10.3233/JAD-141305
Tolerability and Safety of Souvenaid in Patients with Mild Alzheimer's Disease: Results of Multi-Center, 24-Week, Open-Label Extension Study
The 4 references without a DOI — listed, not checked
no DOI — not checkedRisk Reduction of Cognitive Decline and Dementia: WHO Guidelines
no DOI — not checkedEndpoints for pre‐dementia AD trials: a report from the EU/US/CTAD Task Force
no DOI — not checkedFINGER: The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) (FINLAND). Available at:http://wwfingers.com/finger/. Accessed December 13 2019.
no DOI — not checkedMIND‐AD: MIND‐AD: Multimodal preventive trials for Alzheimer's Disease: towards multinational strategies (MIND‐AD) trial. (SWEDEN FINLAND FRANCE GERMANY). Available at:http://wwfingers.com/mind-ad/. Accessed December 13 2019.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1002/alz.12172"><img src="https://citestamp.com/citestamped/10.1002/alz.12172/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1002/alz.12172/badge.svg)](https://citestamp.com/citestamped/10.1002/alz.12172)